Epidermal Growth Factor Receptor Mutation: Clinical Trials

1 trial for Epidermal Growth Factor Receptor Mutation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. .

Follow Epidermal Growth Factor Receptor Mutation: new trials by email Literature Review of Epidermal Growth Factor Receptor Mutation trials Research Report on Epidermal Growth Factor Receptor Mutation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Observational Study of Afatinib 30 mg Daily
Afatinib - Non-Small Cell Lung Cancer, Epidermal Growth Factor Receptor Mutation
UnknownNational University Hospital, Singapore692022-10-252024-05-17

Narrower conditions

Carcinoma, Non-Small-Cell Lung (1)

Broader conditions

Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Lung Diseases (1)  ·  Lung Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Neoplasms (1)  ·  Thoracic Neoplasms (1)

Interventions

Afatinib (1)

Sponsors

National University Hospital, Singapore (1)

Countries

Singapore (1)

Results publications

PMID 23816960, PMID 25589191, PMID 27229180, PMID 42381340